An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer

By Tulchinsky Hagit  

Annals of Surgical Oncology, Vol. 15, Iss. 10, 2008-10 ,pp. : 2661-2667

Springer Publishing Company

Access to resources Recommend Favorite

Outcome in Patients with Resectable Locally Recurrent Rectal Cancer After Total Mesorectal Excision with and Without Previous Neoadjuvant Radiotherapy for the Primary Rectal Tumor

By Alberda Wijnand   Verhoef Cornelis   Nuyttens Joost   Rothbarth Joost   Meerten Esther   Wilt Johannes   Burger Jacobus  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 520-526

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Neoadjuvant Therapy in Sphincter-Saving Surgery for Mid and Distal Rectal Cancer

By Leibold Tobias   Guillem José G.  

Cancer Investigation, Vol. 28, Iss. 3, 2010-03 ,pp. : 259-267

Informa Healthcare

Access to resources Recommend Favorite

Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone

By Schroeder Christopher   Gani Cihan   Lamprecht Ulf   von Weyhern Claus Hann   Weinmann Martin   Bamberg Michael   Berger Bernhard  

International Journal of Hyperthermia, Vol. 28, Iss. 8, 2012-12 ,pp. : 707-714

Informa Healthcare

Access to resources Recommend Favorite

Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer

By Nedrebø Bjørn Steinar   Søreide Kjetil   Eriksen Morten Tandberg   Kvaløy Jan Terje   Søreide Jon Arne   Kørner Hartwig  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 933-940

Informa Healthcare

Access to resources Recommend Favorite